Efficient large-scale preparation method and system of lactoyl-N-tetrasaccharide (LNT)

By combining solid-phase resin technology with chemical synthesis, the gradual connection of resin connecting arms and sugar-sized donor blocks and photocatalytic cracking is solved, and the problem of low separation and purification efficiency in the preparation of lacticyl-N-tetrasaccharide (LNT) is solved. , realizes efficient large-scale preparation and quality controllability, and is suitable for industrial production.

CN119060103APending Publication Date: 2024-12-03MATERNAL & CHILD HEALTH CARE HOSPITAL OF SHANDONG PROVINCE SHANDONG UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411139495.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing preparation methods of lacticyl-N-tetrasaccharide (LNT) require complex separation and purification steps, resulting in low overall preparation efficiency and difficult to achieve efficient and large-scale preparation.

Method used

The solid-phase resin technology is combined with chemical synthesis, and the lactose, glucose and galactose donor blocks are gradually connected through the resin connecting arms, and continuous deprotection and photocatalytic cracking are carried out to achieve efficient and large-scale preparation of LNT.

Benefits of technology

This avoids complex separation and purification steps, improves the preparation efficiency of LNT, and achieves efficient large-scale synthesis at the level of dozens of grams, ensures the structural certainty and quality controllability of the product, laying the foundation for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060103A_ABST
    Figure CN119060103A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of carbohydrate synthesis, discloses an efficient large-scale preparation method and system of LNT tetrasaccharide, and aims to provide an efficient large-scale synthesis method of a human milk oligosaccharide core tetrasaccharide structure, namely lactyl-N-tetrasaccharide (LNT). According to the method, the target molecules are connected to the resin by using the resin, and after continuous chemical reaction, the target product is finally obtained by photocatalytic breaking, so that continuous operation of the chemical reaction is realized, complex separation and purification are avoided, efficient large-scale preparation of the LNT is realized, and the preparation cost is effectively reduced. The preparation method comprises the following steps: firstly, coupling a connecting arm 4 and resin to obtain a resin conjugate, then connecting lactose, glucosamine and galactose to the resin through glycosylation modular reaction in sequence to obtain fully protected LNT, and then performing continuous deprotection to obtain resin connected bare LNT tetrasaccharide; and finally, breaking the LNT from the resin through photocatalytic cracking reaction to obtain the natural LNT.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of carbohydrate synthesis, and in particular relates to a high-efficiency large-scale preparation method and system of lactoyl-N-tetraose (LNT). Background Art

[0002] Breast milk is the best source of nutrients for infant growth and development. Human milk oligosaccharides, as the third largest solid content in breast milk after lactose and fat, play an important role in improving immunity, increasing resistance and promoting brain development. Lactoyl-N-tetraose (LNT), as an important human milk oligosaccharide component, can exist in breast milk as a free tetrasaccharide, or it can be fucosylated or sialylated, and exist in breast milk as oligosaccharides modified by fucosylation or sialylation. Because LNT has good safety for newborns and important physiological functions such as immune regulation and improving resistance, it has obtained the Generally Recognized as Safe (GRAS) certification from the US FDA and has been approved by Nestlé ( Supreme) and Wyeth ( International milk powder giants such as LUXA) add it to their respective milk powder formulas.

[0003] The structure of LNT tetrasaccharide is shown in the figure below:

[0004]

[0005] In view of the above situation, it is very valuable to synthesize LNT efficiently and on a large scale and add it to milk powder. At present, there are three ways to obtain lactoyl-N-tetraose (LNT): extraction, biosynthesis (in vitro enzymatic synthesis and in vivo microbial cell factory synthesis), and chemical synthesis.

[0006] The first method is to extract it from human milk or other animal milk. Due to the low content in natural milk, limited sources, and the need for complex separation and purification, the product quality is difficult to control and the efficiency is low. Therefore, it cannot achieve efficient and large-scale preparation of LNT and has been gradually eliminated.

[0007] The second is biosynthesis, including in vitro enzymatic synthesis and in vivo microbial cell factory synthesis. In vitro enzymatic synthesis: The literature ACS Catalysis, 2019, 9 (12): 10721-10726 reported that the key precursor trisaccharide LNT II was first prepared; then, 130 mg of LNT tetrasaccharide was prepared using β-1,3-galactosyltransferase WbgO from Escherichia coli and UDP-galactose as a substrate. In vivo microbial cell factory synthesis: Invention patent CN113652385B reported that a strain that efficiently produces lactoyl-N-trisaccharide II was used as the starting strain, and the efficient β-1,3-galactosyltransferase gene was systematically screened. The β-1,3-galactosyltransferase gene and the key gene UDP-glucose 4 diastereomerase gene (galE) of the enhanced UDP-galactose pathway were co-expressed on the vector pCDFDuet-1, and the synthesis of LNT was achieved in a 3L fermenter, with a yield of 25.49 g / L. Patent CN114990037B reported that a recombinant Escherichia coli with high lactoyl-N-triose II production was used as the starting strain, and a single copy of galE was integrated into the Escherichia coli genome, and ugD was knocked out to alleviate the metabolic shunting of the intermediate product, and the synthesis of LNT was achieved in a 5L fermenter, with a yield of 57.5g / L. Patent CN117586937B integrates the exogenous genes NsplgtA, Pbr3GalT and galE in the lactoyl-N-tetraose synthesis pathway into the host Escherichia coli genome, and knocks out the expression of lacZ to construct a complete synthesis pathway for lactoyl-N-tetraose, without the addition of exogenous plasmids and antibiotics, and achieves the synthesis of LNT in a 5L fermenter, with a yield of 48.3g / L. However, whether it is enzymatic synthesis in vitro or synthesis in a microbial cell factory in vivo, it is still inseparable from complex separation and purification, and the overall preparation efficiency is not high. In particular, although the in vivo microbial cell factory synthesis method has been applied to the large-scale production of LNT, the cost of separation and purification is relatively high due to the complexity and heterogeneity of the metabolites of in vivo microbial cell factories.

[0008] The third method is to chemically synthesize LNT. Schmidt's research group used pure chemical synthesis to synthesize milligram-scale LNT tetrasaccharide. However, each step of chemical synthesis requires separation and purification, and it cannot be operated continuously. Therefore, the overall synthesis efficiency is low, and it is also difficult to achieve efficient and large-scale preparation of LNT.

[0009] The present invention combines solid phase resin technology with chemical synthesis to achieve continuous chemical synthesis reaction, avoid complex separation and purification, and realize efficient large-scale preparation of LNT tetrasaccharide at the level of tens of grams.

[0010] Through the above analysis, the problems and defects of the prior art are as follows:

[0011] The preparation of lactoyl-N-tetraose, whether by extraction, biosynthesis (in vitro enzymatic synthesis and in vivo microbial cell factory synthesis) or conventional chemical synthesis, requires complex separation and purification methods, and the overall preparation efficiency is low, making it difficult to achieve efficient large-scale expansion. Summary of the invention

[0012] In view of the problems existing in the prior art, the present invention provides a method for preparing LNT tetrasaccharide in an efficient and large-scale manner.

[0013] The present invention is achieved by a high-efficiency large-scale preparation method of LNT tetrasaccharide comprising:

[0014] Step 1, select a suitable resin connecting arm;

[0015] The main purpose of human milk oligosaccharide LNT is to be added to milk powder. When the resin linker arm is broken, the LNT anomeric position is a natural hydroxyl group, and the resin linker arm structure 5 is selected.

[0016] Step 2, sequentially connecting a lactose donor building block, a glucosamine donor building block, and a galactose donor building block to a resin connecting arm 5 to obtain a resin-connected fully protected LNT; and performing a continuous deprotection operation to obtain a resin-connected fully exposed LNT;

[0017] Step 3, using photocatalysis to cleave the LNT naked tetrasaccharide from the resin to obtain natural LNT;

[0018] The resin was introduced into the large-scale synthesis of natural LNT tetrasaccharide, achieving the preparation of the tetrasaccharide at the level of tens of grams.

[0019] Furthermore, the chemical structural formula of LNT is:

[0020]

[0021] The efficient synthesis method is:

[0022]

[0023] At room temperature, in dichloromethane solvent, the entire resin linker system was acidified using the acid detergent TMSOTf; in dichloromethane under ice-water bath conditions, NIS / TfOH was used as an activator to connect the disaccharide lactose donor 8 to the resin to obtain an immobilized fully protected disaccharide product; then, methanesulfonic acid and acetic anhydride were used to "block" the unreacted hydroxyl groups, and trifluoroacetic acid was used to remove the propylidene protection to obtain the resin-immobilized disaccharide product 15 with exposed 3,4-dihydroxyl groups;

[0024] The above-mentioned "acidification-glycosylation-blocking-deprotection" reaction steps were repeated on the basis of the disaccharide product 15, the glycosylation donor was replaced with the building block 9, and the naphthylmethyl protecting group was removed by using DDQ to obtain the resin-immobilized trisaccharide product 16 with exposed 3-hydroxyl group; on the basis of the trisaccharide product 16, after acidification with TMSOTf, the glycosylation donor building block 10 was connected to the trisaccharide 16 using the NIS / TfOH activator to obtain the resin-immobilized fully protected tetrasaccharide product 17;

[0025] The fully protected tetrasaccharide product 17 was deprotected by phthaloyl group using ethylenediamine, the 2-amino group of glucosamine was acetylated by pyridine / acetic anhydride, the propylidene and benzylidene protections were removed by trifluoroacetic acid, and then the benzoyl protection was removed by methanol / sodium methoxide. Finally, under ultraviolet light conditions, the tetrasaccharide was quantitatively cleaved from the resin to obtain the natural lactoyl-N-tetrasaccharide (LNT) product.

[0026] Furthermore, in order to obtain a natural LNT tetrasaccharide structure with a naked hydroxyl group at the reducing end, a resin linker shown in structural formula 5 was selected, and the synthesis method thereof was as follows:

[0027]

[0028] Using vanillyl ethyl ketone compound 1 as the starting material and ethanol as the solvent, the phenolic hydroxyl group on the benzene ring is allyl protected under alkaline conditions; then, under acidic heating conditions, the para-position of the methoxy group on the benzene ring is nitrated to obtain compound 2; the carbonyl group is reduced to a hydroxyl group using sodium borohydride, and the allyl protection is removed under the catalysis of tetrakistriphenylphosphine palladium, and finally, it is coupled with a resin under the catalysis of cesium carbonate to obtain building block 5.

[0029] Further, the synthesis method of the glycosyl donor lactose building block 8 is:

[0030]

[0031] Lactose was used as the starting material, fully acetylated under acetic anhydride / pyridine conditions, converted to phenylthioglycoside at the anomeric position under the catalysis of boron trifluoride etherate, and the acetyl group was removed by methanol / sodium methoxide to obtain compound 7; under the catalysis of p-toluenesulfonic acid, the 3,4-hydroxyl groups of galactose were protected by propylidene, and then the remaining hydroxyl groups were benzoylated to obtain the glycosyl donor building block 8.

[0032] Further, the synthesis method of the glycosyl donor glucosamine building block 9 is:

[0033]

[0034] Using glucosamine as the starting material, compound 11 was obtained after aminophthaloyl protection and full acetylation. The anomeric position was converted to p-toluene glucosinolate under the catalysis of boron trifluoride etherate, and the acetyl group was removed by methanol / sodium methoxide to obtain compound 12. 4,6-Hydroxybenzylidene was protected under the catalysis of p-toluenesulfonic acid, and 3-hydroxynaphthylmethylation was protected under alkaline conditions to obtain the glucosamine glycosyl donor building block 9.

[0035] Further, the synthesis method of the glycosyl donor galactose building block 10 is:

[0036]

[0037] Galactose was used as the starting material, and compound 13 was obtained by full acetylation under acetic anhydride / pyridine conditions, conversion of the anomeric position to p-toluene glucosinolate under the catalysis of boron trifluoride, and deacetylation with methanol / sodium methoxide. 3,4-Hydroxypropylidene protection was catalyzed by p-toluenesulfonic acid, and benzoylation was performed under the catalysis of pyridine to obtain the galactose glycosyl donor building block 10.

[0038] Another object of the present invention is to provide an efficient and large-scale preparation system of LNT tetrasaccharide, comprising:

[0039] A selection module is used to select a suitable resin linker arm; the main purpose of human milk oligosaccharide LNT is to be added to milk powder. When the resin linker arm is broken, the LNT anomeric position is a natural hydroxyl group, and the resin linker arm structure 5 is selected.

[0040] A connection module is used to sequentially connect a lactose donor building block, a glucosamine donor building block, and a galactose donor building block to a resin connection arm 5 to obtain a resin-connected fully protected LNT; and a resin-connected fully exposed LNT is obtained by continuous deprotection operation;

[0041] The cleavage module is used to cleave LNT naked tetrasaccharide from the resin using photocatalysis to obtain natural LNT.

[0042] In combination with the above technical solutions and the technical problems solved, the advantages and positive effects of the technical solutions to be protected by the present invention are as follows:

[0043] First, some creative technical effects are achieved after solving the technical problems existing in the above-mentioned prior art.

[0044] 1. The present invention combines appropriate solid phase resin synthesis with chemical synthesis technology, overcomes the complex separation and purification problems of chemical synthesis, and effectively improves the preparation efficiency of LNT.

[0045] 2. The present invention adopts solid phase resin-chemical synthesis, which is easier to obtain LNT tetrasaccharide compounds with defined structure and controllable quality compared with animal milk extraction and biosynthesis (in vitro enzymatic synthesis and in vivo microbial fermentation); it realizes synthesis of tens of grams on a laboratory scale, which makes it easier to achieve linear amplification, laying the foundation for future industrial-scale production.

[0046] 3. The efficient and large-scale chemical preparation system of LNT tetrasaccharide in the present invention adopts "selection module-connection module-cleavage module" for modular preparation, laying the foundation for the future development of computer-controlled modular assembly system.

[0047] The purpose of the present invention is to provide a human milk oligosaccharide core tetrasaccharide structure: an efficient large-scale synthesis method of lactoyl-N-tetraose (LNT). The method combines solid phase resin technology with chemical synthesis, uses resin to connect the target molecule to the resin, and after continuous chemical reaction, finally uses photocatalytic cleavage to obtain the target product, realizing the continuous operation of chemical reaction, avoiding complex separation and purification, thereby realizing efficient large-scale preparation of LNT and effectively reducing the preparation cost. The present invention first couples the connecting arm 4 and the resin to obtain a resin conjugate, and then lactose, glucosamine and galactose are sequentially connected to the resin through glycosylation modular reaction to obtain fully protected LNT, and then, continuous deprotection is performed to obtain resin-connected naked LNT tetrasaccharide; finally, LNT is cleaved from the resin through a photocatalytic cleavage reaction to obtain natural LNT.

[0048] This method can combine solid-phase resin technology with chemical synthesis technology for the first time, thereby realizing continuous reaction, avoiding complex separation and purification, and achieving efficient large-scale synthesis of LNT at the level of tens of grams.

[0049] Second, as auxiliary evidence of the inventiveness of the claims of the present invention, it is also reflected in the following important aspects:

[0050] (1) The expected benefits and commercial value of the technical solution of the present invention after transformation are as follows: LNT has good safety for newborns and important physiological functions such as immunomodulation and resistance enhancement. It has obtained GRAS certification and is currently added to the respective milk powder formulas by international milk powder giants such as Nestle and Wyeth. The present invention realizes efficient and large-scale preparation of LNT, avoids complex separation and purification, has good industrial prospects, and can effectively improve the production efficiency of LNT.

[0051] (2) The technical solution of the present invention fills the technical gap in the industry at home and abroad: for the first time, solid-phase resin technology and chemical synthesis technology are combined to achieve the preparation of LNT at the level of tens of grams, avoiding the complex separation and purification technology in the current LNT industrial production process, and providing a new industrialization option.

[0052] Third, the present invention provides an efficient and large-scale preparation method of LNT tetrasaccharide, which solves the problems of low efficiency and low yield in traditional methods and realizes the preparation of natural LNT tetrasaccharide at the level of tens of grams. By selecting a suitable resin linker and sequentially connecting lactose donor building blocks, glucosamine donor building blocks and galactose donor building blocks, and then undergoing continuous deprotection and photocatalytic cleavage operations, a LNT tetrasaccharide product with a complete structure and a natural hydroxyl group at the reducing end is successfully obtained.

[0053] The preparation method of the present invention uses a resin linker system as a support to perform step-by-step connection and deprotection operations of fully protected glycosyl building blocks on the resin. In particular, in a dichloromethane solvent, NIS / TfOH is used as an activator, and through multiple steps of acidification, glycosylation and deprotection reactions, an immobilized tetrasaccharide product is finally obtained, and the natural LNT tetrasaccharide is efficiently cleaved from the resin through a photocatalytic process under ultraviolet light.

[0054] In view of the synthesis process of LNT tetrasaccharide, the present invention specially designs a method for synthesizing efficient resin linker arms and glycosyl donor building blocks. For example, by converting vanillyl acetone compounds, a resin linker arm with good binding ability is prepared, ensuring the efficient synthesis of natural structure LNT tetrasaccharide. In addition, in the synthesis process of glycosyl donor building blocks such as lactose, glucosamine and galactose, a series of steps for introducing and removing protecting groups are adopted to optimize the chemical reactivity and selectivity of glycosyl building blocks.

[0055] The present invention effectively improves the yield and purity of LNT tetrasaccharide by optimizing the synthesis strategy and operation steps, breaking through the limitations of traditional methods. This efficient preparation method can not only meet the research needs of laboratory scale, but also lays the foundation for the industrial production of LNT tetrasaccharide, with significant technical progress and application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0056] Figure 1 The figure is a flow chart of the efficient and large-scale preparation method of LNT tetrasaccharide provided in the embodiment of the present invention.

[0057] Figure 2 It is a structural block diagram of the efficient and large-scale preparation system of LNT tetrasaccharide provided by an embodiment of the present invention.

[0058] Figure 3 It is a synthetic route diagram of the resin connecting arm 5 provided in an embodiment of the present invention.

[0059] Figure 4 This is a synthetic route diagram of the lactose glycosyl donor building block 8 provided in an embodiment of the present invention.

[0060] Figure 5 This is a synthetic route of the glucosamine glycosyl donor building block 9 provided in an embodiment of the present invention.

[0061] Figure 6 1 is a synthetic route diagram of the galactose glycosyl donor building block 10 provided in an embodiment of the present invention.

[0062] Figure 7 The synthetic route of lactoyl-N-tetraose (LNT) provided in the embodiment of the present invention is shown in FIG.

[0063] Figure 8 It is the lactoyl-N-tetraose (LNT) provided by the embodiment of the present invention. 13 C spectrum.

[0064] Fig. 9 It is the lactoyl-N-tetraose (LNT) provided by the embodiment of the present invention. 1 H spectrum.

[0065] Fig.10 The NMR of compound 4 1 H spectrum.

[0066] Fig.11 The NMR of compound 4 13 C spectrum. DETAILED DESCRIPTION

[0067] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0068] Example 1: Application in the maternal and infant nutrition industry

[0069] In the maternal and infant nutrition industry, LNT (lactoyl-N-tetraose) is an important human milk oligosaccharide and is widely used in infant formula milk powder. Through the efficient and large-scale preparation method described in the present invention, high-purity natural LNT tetrasaccharide can be produced in large quantities on an industrial scale, and then added to infant formula milk powder to simulate the oligosaccharide components in breast milk, promote the healthy development of infant intestinal flora, and enhance immunity. The high yield and high purity of this method ensure the stability and safety of product quality, and meet the market demand for high-quality infant formula milk powder.

[0070] Example 2: Application in the food additive industry

[0071] In the food additive industry, LNT tetrasaccharide is used in the development of functional foods because of its ability to promote the growth of beneficial bacteria. By utilizing the efficient preparation method of the present invention, high-purity LNT tetrasaccharide can be obtained in the industrial production process and added as a food additive to functional foods such as yogurt, beverages, and nutrition bars. By adding LNT tetrasaccharide, these foods can not only enhance intestinal health, but also have the effect of regulating immune function, thereby improving the market competitiveness of the products and meeting consumers' demand for healthy foods.

[0072] These embodiments demonstrate the specific application of LNT tetrasaccharide in the industry, and reflect the broad prospects and technical advantages of the present invention in the maternal and infant nutrition products and food additives industries.

[0073] like Figure 1 As shown, an efficient and large-scale preparation method of LNT tetrasaccharide provided in an embodiment of the present invention comprises the following steps:

[0074] S101, select a suitable resin connecting arm;

[0075] The main purpose of human milk oligosaccharide lactoyl-N-tetraose (LNT) is to be added to milk powder. When the resin linker arm is broken, the anomeric position of LNT is a natural hydroxyl group, and the resin linker arm structure 5 is selected.

[0076] S102, sequentially connecting a lactose donor building block, a glucosamine donor building block, and a galactose donor building block to a resin connecting arm 5 to obtain a resin-connected fully protected LNT; and performing a continuous deprotection operation to obtain a resin-connected fully exposed LNT;

[0077] S103, using photocatalysis to cleave LNT naked tetrasaccharide from the resin to obtain native LNT;

[0078] The resin was introduced into the large-scale synthesis of natural LNT tetrasaccharide, achieving the preparation of the tetrasaccharide at the hundred-gram level.

[0079] Step S101: Select a suitable resin connecting arm

[0080] In this step, a suitable resin linker structure 5 is selected for the synthesis of human milk oligosaccharide lactoyl-N-tetraose (LNT). The main use of LNT is to be added to milk powder as a functional ingredient. The anomeric position of LNT naturally carries a hydroxyl group, which means that the chemical integrity of this position needs to be maintained during the synthesis process. The selection of the resin linker structure 5 is based on its ability to form a stable connection with the hydroxyl group of LNT and to achieve effective cleavage in subsequent steps, thereby ensuring that the structure and functionality of LNT are not affected.

[0081] Step S102: LNT synthesis and deprotection

[0082] In this step, the synthesis process involves sequentially attaching lactose, glucosamine, and galactose donor building blocks to pre-selected resin linker arms 5. The order of attachment of these building blocks and the chemical reaction conditions are carefully designed to ensure that each building block can be attached to the exact right position of the LNT.

[0083] 1) Connection of lactose donor building block: First, the lactose donor is connected to the resin connecting arm 5. This step usually combines an active site of the lactose donor with a reactive site on the resin connecting arm 5 through a chemical reaction (such as esterification or etherification).

[0084] 2) Attachment of the glucosamine donor building block: Next, the glucosamine donor is attached to the intermediate to which the lactose has been attached. The reaction conditions of this step need to be controlled to ensure that the glucosamine reacts only at the target position.

[0085] 3) Connection of galactose donor building block: Finally, the galactose donor building block is connected to the reaction product of the previous step to complete the fully protected structure of LNT.

[0086] After the above connection is completed, the resin-connected fully protected LNT is obtained. In order to obtain biologically active LNT, a deprotection operation is required, which is usually performed through a series of chemical reactions (such as acid hydrolysis or alkaline hydrolysis) to remove the protecting groups, and finally form a resin-connected fully exposed LNT.

[0087] Step S103: Photocatalytic pyrolysis

[0088] In this step, the fully exposed LNT tetrasaccharide is cleaved from the resin linker using photocatalysis to obtain native LNT. Photocatalytic cleavage is a method that uses light energy to initiate chemical reactions, usually by exciting a catalyst (such as titanium dioxide) with ultraviolet or visible light to produce reactive intermediates that can break the chemical bond between the resin and LNT.

[0089] 1) Photocatalytic reaction conditions: The reaction needs to be carried out under the irradiation of light of a specific wavelength to activate the photocatalyst and ensure that the cleavage process is limited to the bond breakage between the resin linker and the LNT without destroying the structure of the LNT.

[0090] 2) Release and purification of LNT: After the photocatalytic cracking is completed, LNT is released from the resin. Then, LNT is separated from the resin by filtration or centrifugation. Finally, LNT is purified using techniques such as high-performance liquid chromatography (HPLC) to obtain high-purity natural LNT.

[0091] Through the above steps, this method successfully introduced the resin connection technology into the large-scale synthesis of natural LNT tetrasaccharide, and achieved the preparation of LNT at the 100-gram level. This method not only improves the synthesis efficiency of LNT, but also ensures the quality and consistency of the product, and is suitable for large-scale industrial production.

[0092] The chemical structural formula of LNT provided in the embodiment of the present invention is:

[0093]

[0094] The efficient synthesis method is:

[0095]

[0096] At room temperature, in dichloromethane solvent, the entire resin linker arm system was acidified using the acid detergent trimethylsilyl trifluoromethanesulfonate (TMSOTf); in dichloromethane under ice-water bath conditions, N-iodosuccinimide / trifluoromethanesulfonic acid (NIS / TfOH) was used as an activator to connect the disaccharide lactose donor 8 to the resin to obtain an immobilized fully protected disaccharide product; then, methanesulfonic acid and acetic anhydride were used to "block" the unreacted hydroxyl groups, and trifluoroacetic acid was used to remove the propylidene protection to obtain the resin-immobilized disaccharide product 15 with exposed 3,4-dihydroxyl groups;

[0097] The above-mentioned "acidification-glycosylation-blocking-deprotection" reaction steps were repeated on the basis of the disaccharide product 15, the glycosylation donor was replaced with the building block 9, and the naphthylmethyl protecting group was removed by using 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) to obtain the resin-immobilized trisaccharide product 16 with exposed 3-hydroxyl group; on the basis of the trisaccharide product 16, after acidification with TMSOTf, the glycosylation donor building block 10 was connected to the trisaccharide 16 using the NIS / TfOH activator to obtain the resin-immobilized fully protected tetrasaccharide product 17;

[0098] The fully protected tetrasaccharide product 17 was deprotected by phthaloyl group using ethylenediamine, the 2-amino group of glucosamine was acetylated by pyridine / acetic anhydride, the propylidene and benzylidene protections were removed by trifluoroacetic acid, and then the benzoyl protection was removed by methanol / sodium methoxide. Finally, under ultraviolet light conditions, the tetrasaccharide was quantitatively cleaved from the resin to obtain the natural lactoyl-N-tetrasaccharide (LNT) product.

[0099] In order to obtain a natural LNT tetrasaccharide structure with a naked hydroxyl group at the reducing end provided in the embodiment of the present invention, a resin linker shown in structural formula 5 is selected, and the synthesis method thereof is as follows:

[0100]

[0101] Using vanillyl ethyl ketone compound 1 as the starting material and ethanol as the solvent, the phenolic hydroxyl group on the benzene ring is allyl protected under alkaline conditions; then, under acidic heating conditions, the para-position of the methoxy group on the benzene ring is nitrated to obtain compound 2; the carbonyl group is reduced to a hydroxyl group using sodium borohydride, and the allyl protection is removed under the catalysis of tetrakistriphenylphosphine palladium, and finally, it is coupled with a resin under the catalysis of cesium carbonate to obtain building block 5.

[0102] The synthesis method of the glycosyl donor lactose building block 8 provided in the embodiment of the present invention is:

[0103]

[0104] Lactose was used as the starting material, fully acetylated under acetic anhydride / pyridine conditions, converted to phenylthioglycoside at the anomeric position under the catalysis of boron trifluoride etherate, and the acetyl group was removed by methanol / sodium methoxide to obtain compound 7; under the catalysis of p-toluenesulfonic acid, the 3,4-hydroxyl groups of galactose were protected by propylidene, and then the remaining hydroxyl groups were benzoylated to obtain the glycosyl donor building block 8.

[0105] The synthesis method of the glycosyl donor glucosamine building block 9 provided in the embodiment of the present invention is:

[0106]

[0107] Using glucosamine as the starting material, compound 11 was obtained after aminophthaloyl protection and full acetylation. The anomeric position was converted to p-toluene glucosinolate under the catalysis of boron trifluoride etherate, and the acetyl group was removed by methanol / sodium methoxide to obtain compound 12. 4,6-Hydroxybenzylidene was protected under the catalysis of p-toluenesulfonic acid, and 3-hydroxynaphthylmethylation was protected under alkaline conditions to obtain the glucosamine glycosyl donor building block 9.

[0108] The synthesis method of the glycosyl donor galactose building block 10 provided in the embodiment of the present invention is:

[0109]

[0110] Galactose was used as the starting material, and compound 13 was obtained by full acetylation under acetic anhydride / pyridine conditions, conversion of the anomeric position to p-toluene glucosinolate under the catalysis of boron trifluoride, and deacetylation with methanol / sodium methoxide. 3,4-Hydroxypropylidene protection was catalyzed by p-toluenesulfonic acid, and benzoylation was performed under the catalysis of pyridine to obtain the galactose glycosyl donor building block 10.

[0111] like Figure 2 As shown, an efficient and large-scale preparation system of LNT tetrasaccharide provided in an embodiment of the present invention comprises:

[0112] A selection module is used to select a suitable resin linker arm; the main purpose of human milk oligosaccharide LNT is to be added to milk powder. When the resin linker arm is broken, the LNT anomeric position is a natural hydroxyl group, and the resin linker arm structure 5 is selected.

[0113] A connection module is used to sequentially connect a lactose donor building block, a glucosamine donor building block, and a galactose donor building block to a resin connection arm 5 to obtain a resin-connected fully protected LNT; and a resin-connected fully exposed LNT is obtained by continuous deprotection operation;

[0114] The cleavage module is used to cleave LNT naked tetrasaccharide from the resin using photocatalysis to obtain natural LNT.

[0115] Another object of the present invention is to provide a computer device, comprising a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the efficient and large-scale preparation method of LNT tetrasaccharide.

[0116] The present invention provides a method for efficiently and scalably synthesizing the core tetrasaccharide of human milk oligosaccharide: lactoyl-N-tetraose (LNT) by using solid phase synthesis technology, comprising: first preparing a resin linker arm structure 5, then sequentially connecting a lactose donor building block, an amine glucosamine donor building block, and a galactose donor building block to the resin linker arm 5 to obtain resin-linked fully protected LNT, and then removing the protecting group and cleaving it from the resin to obtain natural LNT.

[0117] The lactose donor building block is shown in Formula I, the glucosamine donor building block is shown in Formula II, and the galactose donor building block is shown in Formula III:

[0118]

[0119] Wherein, LG includes sulfhydryl, ester, selenophenyl, halogen, imide ester, phosphonate, ether but not limited to ethylthio, p-tolylthio, phenylthio, acetyl, fluorine, chlorine, bromine, trichloroacetimidate, N-phenyltrifluoroacetimidate, dibutyl phosphate, 4-pentenyloxy;

[0120] R1, R 15 is an ester group, including but not limited to acetyl, pivaloyl, benzoyl, chloroacetyl, levulinyl, and allyloxycarbonyl;

[0121] R2, R3, R4, R5, R6, R7, R8, R9, R 10 , R 11 , R 12 , R 13 , R 14 It is an ester group or an ether group, including but not limited to acetyl, pivaloyl, benzoyl, chloroacetyl, levulinyl, allyloxycarbonyl, benzyl, p-methoxybenzyl, 2-naphthylmethyl, allyl, and trityl.

[0122] In order to fully illustrate the preparation concept of the present invention, the process of this scheme is described below in conjunction with specific embodiments; the structural characterization of the compounds in the present invention is carried out by nuclear magnetic resonance spectroscopy (carbon spectrum and hydrogen spectrum) and mass spectrometry.

[0123] Example 1

[0124] Synthesis of Resin Linker 5:

[0125] like Figure 3 As shown, vanillyl ethyl ketone compound 1 is used as the starting material and ethanol is used as the solvent. The phenolic hydroxyl group on the benzene ring is allyl protected under alkaline conditions; then, under acidic heating conditions, the para-position of the methoxy group on the benzene ring is nitrated to obtain compound 2. The carbonyl group is reduced to a hydroxyl group using sodium borohydride, and the allyl protection is removed under the catalysis of tetrakistriphenylphosphine palladium. Finally, the building block 5 is coupled with the resin under the catalysis of cesium carbonate.

[0126] Specific experimental operations and steps:

[0127] Compound 2: At room temperature, dissolve vanillyl acetone compound 1 (150.2 g, 0.9 mol) in ethanol (500.0 mL), slowly add potassium carbonate K2CO3 (137.1 g, 0.99 mol) and allyl bromide (86.1 mL, 0.99 mol), slowly raise the temperature to reflux, and react overnight until the reaction is complete as detected by TLC. Use an oil pump to spin dry the ethanol, add dichloromethane (300.0 mL) to dilute the system, and wash with saturated brine.

[0128] The organic phase was dried and evaporated to dryness under reduced pressure. The crude product was separated and purified using a silica gel column (n-hexane: ethyl acetate = 3:1).

[0129] A yellow oil (183.1 g, 98%) was obtained. Under argon, the yellow oil (183.1 g, 0.88 mol) was dissolved in trifluoroacetic acid (500.0 mL), cooled to 10 ° C, potassium nitrate KNO3 (98.6 g, 0.98 mol) was added in batches, and then the temperature was slowly raised to 60 ° C for reaction until the reaction was completed by TLC monitoring. 1 L of dichloromethane and ice water were added to the reaction system, and saturated sodium bicarbonate solution was added to neutralize trifluoroacetic acid until no bubbles appeared. After separation, the organic phase was dried over anhydrous sodium sulfate, filtered and concentrated. The crude product was separated and purified by silica gel column (n-hexane: ethyl acetate = 3: 1) to obtain compound 2 (134.1 g, 60%). 1H-NMR (400MHz, CDCl3) δ7.59 (s, 1H), 6.75 (s, 1H), 6.05 (ddt, J=17.3Hz, 10.7Hz, 5.5Hz, 1H), 5.45 (dd, J=17 .2Hz, 1.5Hz, 1H), 5.36 (dd, J=10.6Hz, 1.3Hz, 1H), 4.68 (dt, J=5.5Hz, 1.5Hz, 2H), 3.96 (s, 3H), 2.47 (s, 3H); 13 C-NMR: (100MHz, CDCl3) δ200.26, 154.35, 148.44, 138.25, 132.98, 131.57, 119.55, 108.76, 108.39, 70.30, 56.76, 30.51; m / z (HRMS+) forC 12 H 14 NO5[M+H] +

[0130] calcd.252.0866,found:252.0875.

[0131] Compound 3: Under ice-water bath conditions, compound 2 (134.1 g, 0.53 mol) was dissolved in ethanol (1.5 L) under argon protection, sodium borohydride NaBH4 (40.0 g, 1.06 mol) was added in batches, and the temperature was slowly raised to room temperature for reaction, and TLC was monitored until the reaction was completed. Under ice-water bath conditions, acetone was slowly added to quench the reaction.

[0132] The solvent was dried by spin drying, and then 500 ml of ethyl acetate was added to dissolve the crude product. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product was separated and purified by silica gel column (n-hexane: ethyl acetate = 2:1) to obtain yellow solid compound 3 (120.1 g, 90%). 1 H NMR (400MHz, CDCl3) δ7.54 (s, 1H), 7.29 (s, 1H), 6.05 (ddt, J=17.2, 10.7, 5.5Hz, 1H), 5.53 (q, J=

[0133] 6.2Hz, 1H), 5.46 (dq, J=17.2, 1.5Hz, 1H), 5.34 (dq, J=

[0134] 10.6, 1.3Hz, 1H), 4.64 (dt, J=5.5, 1.5Hz, 2H), 3.97 (s, 3H), 1.53 (d, J=6.3Hz, 3H); 13 C NMR(101MHz,Chloroform-d)δ

[0135] 154.13, 146.53, 139.46, 137.16, 132.04, 119.25, 109.34, 108.69, 70.17, 65.83, 56.50, 24.36.m / z (HRMS+) for C 12 H 16 NO5[M+H] + calcd.

[0136] 254.1023, found:254.1019.

[0137] Compound 4: Under argon, compound 3 (120.1 g, 0.48 mol) was dissolved in anhydrous methanol (500 ml), and a catalytic amount of tetrakis(triphenylphosphine)palladium Pd(PPh3)4 (3.46 g, 3.0 mmol) was added. After stirring for 5 minutes, K2CO3 (62.5 g, 450 mmol) was added. The reaction was allowed to react overnight, and the reaction was monitored by TLC until completion. Subsequently, citric acid (1 M) was added to wash and quench the reaction, and dichloromethane was added to extract. After separation, the organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated. The crude product was separated and purified by silica gel column (dichloromethane: ethyl acetate = 2: 1) to obtain yellow solid compound 4 (90.3 g, 89%). 1 H-NMR (400MHz, acetone-d6) δ8.48 (s, 1H), 7.45 (d, J=5.3Hz, 2H), 5.43 (qd, J=6.2, 4.1Hz, 1H), 4.54 (d, J=4.1Hz, 1H), 3.97 (s, 3H), 2.05 (p, J=

[0138] 2.2Hz, 1H), 1.44 (d, J=6.2Hz, 3H); 13 C NMR (100MHz, acetone-d6) δ206.26, 152.88, 145.78, 137.34, 111.40, 109.54, 65.37, 56.36, 25.34.m / z (HRMS+) for C9H 11 NO5Na[M+Na] + calcd.236.0529, found 236.0926.

[0139] Compound 5: Merrifield resin LL (100-200mesh, initial loading 0.5mmol / g, 220g, 110mmol) was washed three times with dichloromethane, filtered and dried, and then added to dimethylformamide DMF, followed by compound 4 (90.3g, 424mmol), cesium carbonate Cs2CO3 (179.3g, 0.55mol) and tetrabutylammonium bromide TBAI (40.7g, 0.11mol); 600mbar pressure, 60℃, shake for 48 hours. Filter, wash with 500ml H2O, THF, DMF, MeOH, CH2Cl2 in sequence. Then, dry in the dark for 24 hours to prepare compound 5 (0.35mmol / g).

[0140] Synthesis of lactose glycosyl donor building block 8:

[0141] like Figure 4 As shown, lactose is used as the starting material, fully acetylated under acetic anhydride / pyridine conditions, converted to phenylthioglycoside at the anomeric position under the catalysis of boron trifluoride etherate, and the acetyl group is removed by methanol / sodium methoxide to obtain compound 7;

[0142] Under the catalysis of p-toluenesulfonic acid, the 3,4-hydroxyl groups of galactose were protected by propylidene, and then the remaining hydroxyl groups were benzoylated to obtain the glycosyl donor building block 8.

[0143] Specific experimental operations and steps:

[0144] Compound 7:

[0145] Under ice-water bath conditions, D-lactose (100.0 g, 0.30 mol) was dissolved in pyridine (200 ml) and acetic anhydride (800 mL), and then a catalytic amount of DMAP (20 mg) was added. The temperature was slowly raised to room temperature. The reaction was monitored by TLC until the starting material disappeared. The reaction system was cooled to room temperature and poured into ice water. The mixture was extracted with dichloromethane (1.5 L). The organic phase was washed three times with saturated sodium bicarbonate solution (500 ml) and saturated sodium chloride solution (500 ml). The organic phase was collected, dried over anhydrous sodium sulfate, filtered and dried, dissolved in boiling ethanol, and cooled to crystallize to obtain a white solid (178.4 g, 90%). The fully acetylated lactose white solid compound (178.4 g, 0.26 mol) was dissolved in dichloromethane (60 mL), and thiophenol (37.2 g, 0.3 mol) was added under argon protection. After stirring at room temperature for 2 hours, the temperature was lowered to 0°C, and boron trifluoride ether BF·Et2O (48%, 100.2 mL, 0.39 mol) was slowly added dropwise. The reaction was allowed to react overnight at room temperature. The reaction solution was filtered using diatomaceous earth and poured into ice water. The mixture was extracted with dichloromethane (1000 mL), and the organic phase was washed three times with saturated sodium chloride solution (1000 mL). The organic phase was collected, dried over anhydrous sodium sulfate, filtered and dried by spin drying. The crude product was separated by column chromatography with the eluent ratio of petroleum ether:ethyl acetate = 1:1 to obtain a white solid compound (108.2 g, 60%). The white solid compound (108.2 g, 0.15 mol) obtained by separation and purification in the previous step was dissolved in methanol (500 ml), and sodium methoxide (900 mg, 16.9 mmol) was added. After stirring at room temperature for 2 hours, an acidic resin was added until neutral. After filtering, the mother liquor was dried to obtain a white solid compound 7 (62.5 g, 0.15 mol).

[0146] Compound 8:

[0147] Compound 7 (62.5 g, 0.15 mol) was dissolved in anhydrous DMF (500 mL) and dry acetone (1000 mL), and 2,2-dimethoxypropane (30 mL) and p-toluenesulfonic acid (2.59 g, 13.67 mmol) were added in sequence, and stirred at room temperature until the reaction was completed by TLC monitoring. After the reaction was completed, triethylamine was neutralized and concentrated under reduced pressure. Recrystallization was performed using hot ethanol to obtain a white solid (40.0 g, 76.8 mmol, 60%) protected by 3,4-hydroxypropylidene. The white solid (40.0 g, 76.8 mmol) was dissolved in anhydrous pyridine (700 mL), and benzoyl chloride (188.9 mL, 1.63 mol) and 4-dimethylaminopyridine DMAP (4.48 g, 37.1 mmol) were subsequently added, and TLC monitoring was performed until the reaction was completed. Ethyl acetate (500.0 mL) was added to the system for dilution, and the mixture was washed with saturated sodium bicarbonate solution and saturated brine in sequence, the organic phase was dried over anhydrous sodium sulfate, and evaporated to dryness under reduced pressure. The crude product was recrystallized from (n-hexane: ethyl acetate = 3:1) to obtain white crystals 8 (112.5 g, 90%). 1 HNMR (500MHz, CDCl3) 8.07 (d, J=7.8Hz, 2H,), 8.00 (d, J=7.8Hz, 2H), 7.96 (d, J=8.0Hz, 4H), 7.92 (d, J=7.8Hz, 2H), 7.62 –7.09 (m, 20H), 5.73 (t, J = 9.5Hz, 1H), 5.40 (t, J = 9.9Hz, 1H), 5.13 (t, J = 7.6Hz, 1H), 4.88 (d, J = 9.9Hz, 1H), 4.65 (d, J = 12 .0Hz, 1H), 4.59(d, J=7.6Hz, 1H), 4.47(dd, J=12.0Hz, J=5.1Hz, 1H), 4.26–4.21(m, 62H), 4.11(t, J=9.5Hz, 1H), 4.09(d , J=5.8Hz, 1H), 3.89 (dd, J=9.6Hz, J=5.0Hz, 1H), 3.83–3.81 (m, 1H), 3.66 (dd, J=11.2Hz, 1H), 1.52 (s, 3H), 1.25 (s, 3H); 13C NMR (125MHz, CDCl3)166.1, 166.0, 165.7, 165.3, 165.0, 133.52, 133.41, 133.30, 133.11, 133.07, 132.0, 130.31, 130.03, 130.00, 129.93 129.86, 129.72, 129.67, 129.47, 129.40, 128.96, 128.83, 128.63, 128.59, 128.54, 128.53, 128.27, 128.24, 111.0, 100.4, 86.0, 77.4, 77.3, 75.5, 74.0, 73.8, 73.3, 71.5, 70.6, 63.0, 62.9, 27.6, 26.3.

[0148] Synthesis of Glucosyl Donor Building Block 9:

[0149] like Figure 5 As shown, glucosamine is used as the starting material, and compound 11 is obtained after aminophthaloyl protection and full acetylation. The anomeric position is converted to p-toluene glucosinolate under the catalysis of boron trifluoride etherate, and the acetyl group is removed by methanol / sodium methoxide to obtain compound 12; 4,6-hydroxybenzylidene is protected under the catalysis of p-toluenesulfonic acid, and 3-hydroxynaphthyl is methylated under alkaline conditions to obtain glucosamine glycosyl donor building block 9.

[0150] Specific experimental operations and steps:

[0151] Compound 9: According to the method reported in the literature: Journal of the American Chemical Society, 2013, 135 (41): 15382-15391. D-glucosamine was introduced into the anomeric position of p-toluene glucosinolate and the 2-position of phthalic anhydride for protection, and then the acetyl group was removed under methanol / sodium methoxide conditions to obtain compound 12. Compound 12 (31.9 g, 76.9 mmol) was dissolved in dry acetonitrile (350 mL), 4A molecular sieves were added, and benzaldehyde dimethyl acetal (17.5 mL, 0.11 mol) and p-toluenesulfonic acid (1.51 g, 7.7 mmol) were added under argon protection. After reacting at room temperature for 2 hours, TLC monitoring of the disappearance of the raw material was performed, triethylamine (1.2 mL, 9.3 mmol) was added, and the mixture was spin-dried. The crude product was separated by column chromatography using a silica gel column, and the eluent ratio was petroleum ether ethyl acetate = 4:1 to obtain a white solid (33.6 g, 87%). The obtained white solid (33.6 g, 66.6 mmol) was dissolved in dry DMF (300 mL), and 4A molecular sieves were added. The mixture was stirred at room temperature for 2 hours under argon protection, and then moved to an ice-water bath. NaH (4.26 g, 0.105 mol) and naphthylmethyl bromide (19.2 g, 0.087 mol) were added. The reaction was monitored by TLC until the raw materials were completely reacted. Acetic acid was then added to neutralize to neutrality, and the mixture was spin-dried. Column chromatography was performed using a silica gel column, and the eluent ratio was petroleum ether ethyl acetate = 6:1 to obtain white solid compound 9 (30.7 g, 73%). 1 HNMR (600MHz, CDCl3) δ7.77-6.97 (m, 20H, ArH), 5.65 (s, 1H, PhCH), 5.52 (d, J=10.6Hz, 1H, H-1), 4.93 (d, J=12.6Hz.1H, NapCH), 4.62 (d, J=12.6Hz.1H, NapCH), 4.52 (t, J=9.4Hz, 1H, H -3), 4.43 (dd, J=10.6, 4.9Hz, 1H, H-6s), 4.26 (t, J=10.2Hz, 1H, H-2), 3.85 (t, J=10.3Hz, 1 H, H-6R), 3.81 (t, J=9.2Hz, 1H, H-4), 3.72 (td, J=9.7, 5.0Hz, 1H, H-5). 2.28 (s, 3H, SPhCH).

[0152] Synthesis of Galactose Glycosyl Donor Building Block 10:

[0153] like Figure 6As shown, galactose is used as the starting material, and compound 13 is obtained by full acetylation under acetic anhydride / pyridine conditions, conversion of the anomeric position to p-toluene glucosinolate is carried out under the catalysis of boron trifluoride etherate, and deacetylation is carried out under methanol / sodium methoxide. 3,4-Hydroxypropylidene is protected by p-toluenesulfonic acid, and benzoylation is carried out under the catalysis of pyridine to obtain the galactose glycosyl donor building block 10.

[0154] Specific experimental operations and steps:

[0155] Compound 14:

[0156] According to the method reported in the literature: Chem Commun, 2011, 47 (1): 523-525, galactose was used as the starting material to introduce p-toluene glucosinolate at the anomeric position to obtain compound 13. Compound 13 (40 g, 0.14 mol) was dissolved in 2,2-dimethoxypropane (180 mL), camphorsulfonic acid CSA (3.24 g, 14.0 mmol) was added, and stirred for 12 h. Triethylamine (1.94 mL) was added to neutralize to neutrality and then spun dry. After dissolving in methanol (200 mL) and water (2 mL), a catalytic amount (1 drop) of acetic acid was added, and the mixture was heated to reflux until the reaction was completed under TLC monitoring. Recrystallization with methanol gave white solid compound 14 (39.1 g, 88%).

[0157] Compound 10:

[0158] Compound 14 (39.1 g, 0.12 mol) was dissolved in pyridine (100 mL), and benzoyl chloride (33.1 mL) was added under ice bath. After reacting at room temperature for 4 hours, the reaction was completed as monitored by TLC. The reaction solution was poured into ice water, extracted with dichloromethane (500 mL), and the organic phase was washed three times with saturated aqueous sodium bicarbonate solution (500 mL). The organic phase was collected, dried over anhydrous sodium sulfate, filtered and dried, and the crude product was dissolved in boiling methanol and recrystallized to obtain white solid compound 10 (63.1 g, 99%). 1 HNMR (600MHz, CDCl3) δ8.10~8.05 (m, 4H), 7.64-7.54 (m, 2H), 7.50-7.42 (m, 4H), 7.36 -7.31 (m, 2H).6.84 (d, J=8.0Hz, 2H), 5.31 (dd, J=10.1, 7.1Hz, 1H), 4.71 (dd, J=11.1, 4 .1Hz, 2H), 4.62 (dd, J=11.9, 8.3Hz, 1H), 4.38 (dd, J=7.0, 5.4Hz, 1H), 4.32 (dd, J=5.4, 2.1Hz, 1H), 4.19 (ddd, J=8.4, 3.7, 2.2Hz, 1H). 2.21 (s.3H), 1.60 (s, 3H), 1.36 (s, 3H). 13CNMR (151MHz, CDCI3)6166.34.165.44, 137.83, 133.64, 133.23.133.21, 132.44, 130.16, 129.94, 129.86, 129.80, 129.73, 129.54, 128.48, 128.43 , 128.41, 128.37, 111.06, 86.45, 77.30, 77.23, 77.02, 76.80, 74.40, 73.7 2, 72.03, 64.13, 31.82, 29.70, 27.66, 26.90, 26.37, 21.08, 13.73.11.07.

[0159] Synthesis of Lactoyl-N-tetraose (LNT):

[0160] like Figure 7 As shown, at room temperature, in dichloromethane solvent, the entire resin linker arm system was acidified using the acid detergent TMSOTf; in dichloromethane under ice-water bath conditions, the disaccharide lactose donor 8 was connected to the resin using NIS / TfOH as an activator to obtain an immobilized fully protected disaccharide product; then, methanesulfonic acid and acetic anhydride were used to "block" the unreacted hydroxyl groups, and trifluoroacetic acid was used to remove the propylidene protection to obtain the 3,4-dihydroxy-exposed resin-immobilized disaccharide product 15.

[0161] The above-mentioned "acidification-glycosylation-blocking-deprotection" reaction steps were repeated on the basis of the disaccharide product 15, the glycosylation donor was replaced with building block 9, and the naphthylmethyl protecting group was removed using DDQ to obtain the 3-hydroxyl-exposed resin-immobilized trisaccharide product 16. After acidification with TMSOTf on the basis of the trisaccharide product 16, the glycosylation donor building block 10 was connected to the trisaccharide 16 using the NIS / TfOH activator to obtain the resin-immobilized fully protected tetrasaccharide product 17.

[0162] The fully protected tetrasaccharide product 17 was deprotected by phthaloyl group using ethylenediamine, the 2-amino group of glucosamine was acetylated by pyridine / acetic anhydride, the propylidene and benzylidene protections were removed by trifluoroacetic acid, and then the benzoyl protection was removed by methanol / sodium methoxide. Finally, under ultraviolet light conditions, the tetrasaccharide was quantitatively cleaved from the resin to obtain the natural lactoyl-N-tetrasaccharide (LNT) product.

[0163] Figure 8 It is the lactoyl-N-tetraose (LNT) provided by the embodiment of the present invention. 13 C spectrum.

[0164] Fig. 9 It is the lactoyl-N-tetraose (LNT) provided by the embodiment of the present invention. 1 H spectrum.

[0165] Specific experimental operations and steps:

[0166] Preparation of resin-linked disaccharides: "acid washing - glycosylation - "blocking" - deprotection"

[0167] Acid washing of resin linker: The resin linker compound 5 (0.35 mmol / g, 87.5 g) was dissolved in 100 mL of acid solution (0.45 mL of TMSOT in 40 mL of CH2Cl2), filtered and dried.

[0168] Glycosidation reaction: Under argon protection and ice-water bath conditions, the acid-washed compound 5 (0.35 mmol / g, 87.5 g) and 4 equivalents of lactose glycosyl donor compound 8 (110 g, 0.11 mol) were placed in a 1000 mL round-bottom flask, anhydrous dry CH2Cl2 (500 mL) was added, followed by NIS (27.2 g, 0.121 mol) / TfOH (960 uL, 11 mmol). The reaction was completed after shaking for 0.5 hours, filtered, rinsed three times with CH2Cl2 (200 mL x 3), and dried to obtain a resin-linked disaccharide product.

[0169] Block unreacted hydroxyl groups: Place the resin-linked disaccharide in a 500 mL round-bottom flask, add 250 mL of "blocking solution" (1.2 mL of methanesulfonic acid MsOH, 6 mL of acetic anhydride Ac2O, 50 mL of CH2Cl2), shake the reaction for 20 minutes, filter, rinse once with CH2Cl2 (200 mL), and dry.

[0170] Removal of protecting groups: The resin-linked disaccharide was placed in a 500 mL round-bottom flask, CH2Cl2 (300 mL) and trifluoroacetic acid (10 mL) were added, shaken for 20 min, filtered, rinsed once with CH2Cl2 (200 mL), and dried to obtain a resin-linked disaccharide receptor (110.2 g).

[0171] Preparation of resin-linked trisaccharides:

[0172] Acid washing of the resin linker arm: The resin linker arm disaccharide acceptor (110.2 g) was dissolved in 100 mL of acid solution (0.45 mL TMSOTf in 40 mL CH2Cl2), filtered and dried.

[0173] Glycosidation reaction: Under argon protection and ice-water bath conditions, the resin-linked disaccharide acceptor (110.2 g) and 4 equivalents of aminoglucosyl donor compound 9 (66 g, 0.1 mol) were placed in a 1000 mL round-bottom flask, and anhydrous dry CH2Cl2 (500 mL) was added, followed by NIS (27.2 g, 0.121 mol) / TfOH (960 uL, 11 mmol). The reaction was completed after shaking for 0.5 hours, filtered, rinsed three times with CH2Cl2 (200 mL x 3), and dried to obtain a resin-linked trisaccharide product.

[0174] Block unreacted hydroxyl groups: Place the resin-linked trisaccharide in a 500 mL round-bottom flask, add 250 mL of "blocking solution" (1.2 mL MsOH, 6 mL Ac2O, 50 mL CH2Cl2), shake the reaction for 20 minutes, filter, rinse once with CH2Cl2 (200 mL), and dry.

[0175] Removal of protecting groups: The resin-linked trisaccharide was placed in a 500 mL round-bottom flask, CH2Cl2 (300 mL) and H2O (10 mL) and DDQ (12.5 g, 55 mmol) were added, shaken for 60 min, filtered, rinsed once with CH2Cl2 (200 mL), and dried to obtain the resin-linked trisaccharide receptor (130.4 g).

[0176] Preparation of Resin-Linked Tetrasaccharide:

[0177] Acid washing of the resin linker arm: The resin linker arm disaccharide acceptor (130.4 g) was dissolved in 100 mL of acid solution (0.45 mL of TMSOTf in 40 mL of CH2Cl2), filtered and dried.

[0178] Glycosidation reaction: Under argon protection and ice-water bath conditions, the resin-linked trisaccharide acceptor (130.4 g) and 4 equivalents of galactose glycosyl donor compound 10 (292.2 g, 0.9 mol) were placed in a 1000 mL round-bottom flask, and anhydrous dry CH2Cl2 (500 mL) was added, followed by NIS (24.9 g, 0.11 mol) / TfOH (872 uL, 10 mmol). The reaction was completed after shaking for 0.5 hours, filtered, rinsed three times with CH2Cl2 (200 mL X3), and dried to obtain a resin-linked tetrasaccharide fully protected product (195.5 g).

[0179] Preparation of natural LNT tetrasaccharide:

[0180] In a 500mL round-bottom flask, the fully protected product (195.5g) of the resin-linked tetrasaccharide was dissolved in 200mL of tert-butanol, 3mL of ethylenediamine was added, and the mixture was shaken at room temperature for 1 hour, and filtered; pyridine (8.1mL) / acetic anhydride (4.8mL) was added to the resin-linked tetrasaccharide, and the mixture was shaken for 1 hour, and filtered; CH2Cl2 / H2O (200mL, 10:1) solvent was added to the resin-linked tetrasaccharide, and trifluoroacetic acid (5mL) was added, and the mixture was shaken at room temperature for 1 hour, and filtered; methanol / sodium methoxide (0.1M, 200mL) was added to the resin-linked tetrasaccharide, and the mixture was shaken at room temperature for 1 hour, and filtered; the naked LNT tetrasaccharide linked to the resin was placed in a 500mL sealed tube, placed in a UV-150 photoreactor, the light source intensity was adjusted to 80%, and the mixture was shaken at 20°C for 1 hour. Finally, the mixture was filtered, rinsed with methanol (100mL), and the filtrate was collected. After spin drying, LNT tetrasaccharide (38.9 g, 50%) was obtained by recrystallization from ethyl acetate. 1H NMR (400 MHz, D2O) δ5.20 (d, J = 3.7 Hz, 1H), 4.71 (d, J = 8.3 Hz, 1H), 4.64 (d, J = 8.0 Hz, 1H), 4.42 (d, J = 7.7 Hz, 2H), 4.13 (d, J = 3.1 Hz, 1H), 3.95-3.66 (m, 16H), 3.65-3.43 (m, 8H), 3.29-3.22 (m, 1H), 2.01 (s, 3H). 13 C NMR (101MHz, D2O) δ174.96, 103.46, 102.89, 102.54, 95.71, 91.78, 82.02, 81.96, 78.36, 78.25, 75.25, 75.15, 74.87, 74.77, 74 .32, 73.76, 72.43, 71.37, 71.10, 70.65, 70.09, 69.98, 68.51, 68.42, 68.29, 61.01, 60.94, 60.47, 60.05, 59.92, 54.67, 22.21.

[0181] The natural human milk oligosaccharide LNT tetrasaccharide prepared in the present invention is a natural breast milk component and has been added to the formula of milk powder by international milk powder giants. It can be sialylated to obtain the precursor substance for the synthesis of human milk oligosaccharide LSTa pentasaccharide and DSLNT hexasaccharide, and DSLNT plays an important role in preventing neonatal necrotizing enterocolitis. Fig.10 The NMR of compound 4 1 H spectrum; Fig.11 The NMR of compound 4 13 C spectrum.

[0182] It should be noted that the embodiments of the present invention can be implemented by hardware, software, or a combination of software and hardware. The hardware part can be implemented using dedicated logic; the software part can be stored in a memory and executed by an appropriate instruction execution system, such as a microprocessor or dedicated design hardware. It can be understood by a person of ordinary skill in the art that the above-mentioned devices and methods can be implemented using computer executable instructions and / or contained in a processor control code, such as a carrier medium such as a disk, CD or DVD-ROM, a programmable memory such as a read-only memory (firmware), or a data carrier such as an optical or electronic signal carrier. Such code is provided on the carrier medium. The device and its modules of the present invention can be implemented by hardware circuits such as very large-scale integrated circuits or gate arrays, semiconductors such as logic chips, transistors, etc., or programmable hardware devices such as field programmable gate arrays, programmable logic devices, etc., can also be implemented by software executed by various types of processors, and can also be implemented by a combination of the above-mentioned hardware circuits and software, such as firmware.

[0183] The above description is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any modifications, equivalent substitutions and improvements made by any technician familiar with the technical field within the technical scope disclosed by the present invention and within the spirit and principle of the present invention should be covered by the protection scope of the present invention.

Claims

1. An efficient and large-scale preparation method of LNT tetrasaccharide, It is characterized in that The following steps are involved: Step 1, select a suitable resin connecting arm; The main purpose of human milk oligosaccharide LNT is to add it to milk powder. When the resin linker arm is broken, the LNT anomeric position is a natural hydroxyl group, and the resin linker arm structure 5 is selected; Step 2, sequentially connecting a lactose donor building block, a glucosamine donor building block, and a galactose donor building block to a resin connecting arm 5 to obtain a resin-connected fully protected LNT; and performing a continuous deprotection operation to obtain a resin-connected fully exposed LNT; Step 3, using photocatalysis to cleave the LNT naked tetrasaccharide from the resin to obtain natural LNT; The resin was introduced into the large-scale synthesis of natural LNT tetrasaccharide, achieving the preparation of the tetrasaccharide at the hundred-gram level.

2. The efficient and large-scale preparation method of LNT tetrasaccharide according to claim 1, It is characterized in that The chemical structural formula of LNT is: The efficient synthesis method is: At room temperature, in dichloromethane solvent, the entire resin linker system was acidified using the acid detergent TMSOTf; in dichloromethane under ice-water bath conditions, NIS / TfOH was used as an activator to connect the disaccharide lactose donor 8 to the resin to obtain an immobilized fully protected disaccharide product; then, methanesulfonic acid and acetic anhydride were used to "block" the unreacted hydroxyl groups, and trifluoroacetic acid was used to remove the propylidene protection to obtain the resin-immobilized disaccharide product 15 with exposed 3,4-dihydroxyl groups; The above-mentioned "acidification-glycosylation-blocking-deprotection" reaction steps were repeated on the basis of the disaccharide product 15, the glycosylation donor was replaced with the building block 9, and the naphthylmethyl protecting group was removed by using DDQ to obtain the resin-immobilized trisaccharide product 16 with exposed 3-hydroxyl group; on the basis of the trisaccharide product 16, after acidification with TMSOTf, the glycosylation donor building block 10 was connected to the trisaccharide 16 using the NIS / TfOH activator to obtain the resin-immobilized fully protected tetrasaccharide product 17; The fully protected tetrasaccharide product 17 was deprotected by phthaloyl group using ethylenediamine, the 2-amino group of glucosamine was acetylated by pyridine / acetic anhydride, the propylidene and benzylidene protections were removed by trifluoroacetic acid, and then the benzoyl protection was removed by methanol / sodium methoxide. Finally, under ultraviolet light conditions, the tetrasaccharide was quantitatively cleaved from the resin to obtain the natural lactoyl-N-tetrasaccharide (LNT) product.

3. The efficient and large-scale preparation method of LNT tetrasaccharide according to claim 1, It is characterized in that In order to obtain a natural LNT tetrasaccharide structure with a naked hydroxyl group at the reducing end, a resin linker shown in structural formula 5 was selected, and the synthesis method thereof is as follows: Using vanillyl ethyl ketone compound 1 as the starting material and ethanol as the solvent, the phenolic hydroxyl group on the benzene ring is allyl protected under alkaline conditions; then, under acidic heating conditions, the para-position of the methoxy group on the benzene ring is nitrated to obtain compound 2; the carbonyl group is reduced to a hydroxyl group using sodium borohydride, and the allyl protection is removed under the catalysis of tetrakistriphenylphosphine palladium, and finally, it is coupled with a resin under the catalysis of cesium carbonate to obtain building block 5.

4. The efficient and large-scale preparation method of LNT tetrasaccharide according to claim 2, It is characterized in that The synthesis method of the glycosyl donor lactose building block 8 is: Lactose was used as the starting material, fully acetylated under acetic anhydride / pyridine conditions, converted to phenylthioglycoside at the anomeric position under the catalysis of boron trifluoride etherate, and the acetyl group was removed by methanol / sodium methoxide to obtain compound 7; under the catalysis of p-toluenesulfonic acid, the 3,4-hydroxyl groups of galactose were protected by propylidene, and then the remaining hydroxyl groups were benzoylated to obtain the glycosyl donor building block 8.

5. The efficient and large-scale preparation method of LNT tetrasaccharide according to claim 2, It is characterized in that The synthesis method of the glycosyl donor glucosamine building block 9 is: Using glucosamine as the starting material, compound 11 was obtained after aminophthaloyl protection and full acetylation. The anomeric position was converted to p-toluene glucosinolate under the catalysis of boron trifluoride etherate, and the acetyl group was removed by methanol / sodium methoxide to obtain compound 12. 4,6-Hydroxybenzylidene was protected under the catalysis of p-toluenesulfonic acid, and 3-hydroxynaphthylmethylation was protected under alkaline conditions to obtain the glucosamine glycosyl donor building block 9.

6. The efficient and large-scale preparation method of LNT tetrasaccharide according to claim 2, It is characterized in that The synthesis method of the glycosyl donor galactose building block 10 is: Galactose was used as the starting material, and compound 13 was obtained by full acetylation under acetic anhydride / pyridine conditions, conversion of the anomeric position to p-toluene glucosinolate under the catalysis of boron trifluoride, and deacetylation with methanol / sodium methoxide. 3,4-Hydroxypropylidene protection was catalyzed by p-toluenesulfonic acid, and benzoylation was performed under the catalysis of pyridine to obtain the galactose glycosyl donor building block 10.

7. A system for efficiently and scalably preparing LNT tetrasaccharide for implementing the method for efficiently and scalably preparing LNT tetrasaccharide according to any one of claims 1 to 6, It is characterized in that The efficient and large-scale preparation system of LNT tetrasaccharide comprises: A selection module is used to select a suitable resin linker arm; the main purpose of human milk oligosaccharide LNT is to be added to milk powder. When the resin linker arm is broken, the LNT anomeric position is a natural hydroxyl group, and the resin linker arm structure 5 is selected. A connection module is used to sequentially connect a lactose donor building block, a glucosamine donor building block, and a galactose donor building block to a resin connection arm 5 to obtain a resin-connected fully protected LNT; and a resin-connected fully exposed LNT is obtained by continuous deprotection operation; The cleavage module is used to cleave LNT naked tetrasaccharide from the resin using photocatalysis to obtain natural LNT.

Citation Information

Cited By

  • Method for synthesizing blood group antigen NOR1 pentasaccharide by enzyme method

    CN119351496A